Michiganders have some big decisions to make in November —including a choice between electing Kyra Harris Bolden or Patrick O’Grady to a partial term on the state Supreme Court.
Michigan Democrats and Republicans have each nominated two candidates for two open seats on the state Supreme Court
The Republican candidates for the state Supreme Court are standing against Michigan’s women and workers—and the ‘woke rogue liberal bench’ that has sided with them.
Harris and President Biden are calling on Congress to establish term limits and a more binding, enforceable code of ethics for Supreme Court justices. “These popular reforms will help to restore confidence in the Court, strengthen our democracy, and ensure no one is above the law,” Harris said.
Republican state Rep. Andrew Fink is an election denier who has opposed laws to make it easier for Michiganders to vote. This year, he wants a seat on the highest court in the state.
The US Supreme Court has, shall we say, made news this year. Here’s an approachable explainer to some of their top rulings of the term, and how they impact clean air, workplace safety, health insurance, and the general quality of life for all Americans.
The massively consequential ruling from the Supreme Court grants Trump and any future leaders the right to claim immunity from criminal prosecution for “official” acts carried out in office.
The Supreme Court declared that gifts or payments made to state or local officials after they implement certain political or social actions don’t violate the law. In other words, if you want to bribe a public official, as long as you wait until after they do what you want to pay them or give them a gift, it’s totally legal.
The Supreme Court on Monday jumped into the fight over transgender rights, agreeing to hear an appeal from the Biden administration seeking to block state bans on gender-affirming care.
Justice Brett Kavanaugh, writing on behalf of the Supreme Court, wrote that while the plaintiffs did not have standing to sue over the FDA's regulation of mifepristone, “it is not clear that no one else would have standing to challenge the FDA’s relaxed regulation of mifepristone.”
